Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple SclerosisAlessandro Cagol, Tarek Yousry, Jaume Sastre‐Garriga et al.|JAMA Neurology|2023Cited by 64
Cognitive progression independent of relapse in multiple sclerosisTom Fuchs, Ralph H. B. Benedict, Menno M. Schoonheim et al.|Multiple Sclerosis Journal|2024Cited by 34
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre studyMaria A. Rocca, Massimo Filippi, Paola Valsasina et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 34
Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MSDeborah N. Schoonhoven, Eva Strijbis, Matteo Fraschini et al.|Multiple Sclerosis Journal|2018Cited by 32
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple SclerosisEline M. E. Coerver, Eva Strijbis, Wing Hee Fung et al.|JAMA Neurology|2024Cited by 29